diabet
diabet
mellitu
metabol
disord
characteris
excess
level
glucos
blood
accord
emin
diabetologist
robert
tattersal
diabet
singl
diseas
syndrom
least
fifti
possibl
caus
tattersal
bodi
either
manufactur
enough
insulin
cell
respond
effect
insulin
produc
insulin
essenti
hormon
secret
pancrea
enabl
bodi
cell
absorb
glucos
convert
energi
requir
muscl
tissu
function
sinc
person
diabet
abl
properli
metabolis
glucos
blood
may
experi
rais
blood
sugar
hyperglycaemia
time
excess
level
blood
sugar
may
lead
tissu
damag
rang
lifethreaten
health
complic
includ
blind
kidney
failur
cardiovascular
diseas
limb
amput
articl
new
york
time
physician
abigail
zuger
describ
import
insulin
follow
without
insulin
bodi
unabl
use
glucos
primari
fuel
sugar
starch
diabet
diet
turn
poison
clog
bloodstream
unus
glucos
glucos
elimin
sweettast
urin
bodi
cell
liter
starv
midst
plenti
insulindefici
patient
thirsti
raven
eat
faster
wast
away
zuger
term
diabet
deriv
greek
word
diabainem
mean
pass
siphon
molinaro
ancient
greek
understood
diabet
condit
food
liquid
intak
pass
bodi
instead
fuell
nineteenth
centuri
categoris
differ
type
diabet
french
physician
etienn
lancereaux
distinguish
diabet
maigr
thin
diabet
diabet
gra
fat
diabet
tattersal
today
categori
revis
type
diabet
type
diabet
former
common
among
young
peopl
latter
gener
diagnos
adult
popul
former
autoimmun
diseas
associ
destruct
insulinproduc
islet
cell
latter
common
form
diabet
aris
develop
resist
insulin
risk
insulinresist
diabet
increas
age
late
nineteenth
centuri
signific
turn
point
scientif
understand
took
place
oskar
minkowski
joseph
von
mere
demonstr
diabet
induc
remov
pancrea
minkowski
also
demonstr
autotransplant
pancrea
fragment
depancreatis
dog
could
temporarili
prevent
diabet
benedum
follow
work
minkowski
von
mere
physician
began
conduct
experiment
transplant
use
pancreat
tissu
attempt
amelior
diabet
decemb
patrick
watson
william
perform
xenograft
treat
year
old
patient
critic
ill
diabet
bristol
royal
infirmari
william
assist
surgic
colleagu
william
henri
harsant
william
implant
three
fragment
ovin
pancrea
subcutan
tissu
patient
breast
abdomen
fragment
compar
size
brazil
nut
tissu
procur
sheep
freshli
slaughter
addit
ovin
graft
william
also
prescrib
extract
minc
sheep
pancrea
oral
therapi
though
patient
blood
glucos
fell
oper
condit
deterior
die
diabet
coma
day
later
decad
later
jame
allan
physician
glasgow
infirmari
instruct
surgeon
repeat
william
experi
use
pancrea
cat
wish
sheep
pancrea
deem
impractic
allan
report
dr
barlow
perform
oper
skil
final
result
failur
allan
diabet
patient
die
week
transplant
altern
xenograft
surgeon
also
experi
human
pancreat
transplant
australia
earliest
record
surgeri
took
place
launceston
gener
hospit
tasmania
oper
perform
surgeon
superintend
dr
later
sir
john
ramsay
unpublish
paper
ramsay
document
opportun
perform
experiment
procedur
young
male
patient
suddenli
die
heart
excis
small
portion
tail
cadaver
pancrea
ramsay
graft
partial
pancrea
abdomen
year
old
femal
diabet
within
week
oper
led
gradual
reduct
level
glycosuria
presenc
sugar
patient
urin
inde
ramsay
even
report
lowest
level
glycosuria
fell
practic
zero
morri
subsequ
day
howev
rose
preoper
level
indic
graft
failur
implant
tissu
eventu
remov
site
surgeri
becam
inflam
patient
live
anoth
year
transplant
surgeri
follow
ramsay
experi
frederick
charl
pybu
surgeon
newcastleupontyn
also
attempt
allotransplant
royal
victoria
infirmari
pybu
pybu
graft
fragment
cadaver
pancreat
tissu
abdomen
two
diabet
though
mild
reduct
glucos
excret
one
patient
neither
transplant
success
one
patient
die
month
oper
second
die
year
later
pybu
conclud
much
said
principl
graft
seem
abl
understand
must
continu
fail
oper
although
may
appear
ration
treatment
diseas
attempt
pybu
well
known
frederick
bant
colleagu
isol
insulin
laboratori
toronto
univers
interwar
period
though
research
also
conduct
experi
produc
insulin
canadian
research
embark
clinic
trial
commercialis
research
widespread
market
distribut
long
success
isol
insulin
bant
also
attempt
pancreat
autograft
dog
though
without
success
bliss
second
world
war
field
organ
transplant
emerg
follow
success
kidney
transplant
twin
februari
claud
hitchcock
perform
renal
allograft
xenograft
year
old
femal
diabet
endstag
renal
failur
hitchcock
et
al
hitchcock
chief
surgeon
hennepin
counti
hospit
minneapoli
sinc
renal
allograft
reject
day
hitchcock
remov
replac
kidney
baboon
baboon
kidney
function
day
patient
die
hitchcock
describ
experi
first
baboon
renal
heterograft
hitchcock
et
al
three
year
later
decemb
william
kelli
richard
lillehei
perform
first
success
pancrea
transplant
old
patient
type
diabet
receiv
pancrea
segment
along
renal
graft
duodedum
follow
transplant
patient
insulin
independ
day
receiv
irradi
therapi
treat
develop
graft
pancreat
due
organ
reject
kidney
pancrea
later
remov
patient
die
surgic
sepsi
month
oper
sutherland
groth
today
diabet
patient
may
offer
either
kidney
pancrea
transplant
depend
number
consider
includ
patient
renal
function
avail
organ
procedur
term
simultan
pancrea
kidney
transplant
spk
pancrea
kidney
transplant
pak
pancrea
transplant
alon
pta
kidney
transplant
alon
kta
contrast
pancrea
kidney
transplant
simpl
less
invas
altern
islet
transplant
object
procedur
infus
suffici
quantiti
islet
cell
control
level
blood
glucos
therebi
overcom
need
exogen
insulin
insulinproduc
beta
cell
compris
pancrea
requir
tissu
isol
laparoscop
procedur
perform
local
anaesthet
implant
islet
cell
gruessner
gruessner
suggest
pancrea
transplant
could
supplement
islet
transplant
facilit
continu
insulinindepend
gruessner
gruessner
success
islet
transplant
patient
renal
function
avert
need
kidney
transplant
islet
transplant
gener
prescrib
type
diabet
patient
unstabl
diabet
sever
hypoglycaemia
unawar
advis
diabet
patient
due
scarciti
avail
islet
advers
sideeffect
immunosuppress
drug
similarli
process
extract
insulin
separ
islet
pancreat
tissu
difficult
complex
procedur
credit
attribut
paul
laci
colleagu
invent
collagenas
digest
techniqu
necessari
isol
pancreat
islet
laci
kostianovski
scientist
demonstr
islet
transplant
could
revers
diabet
rodent
dog
monkey
balling
laci
mata
et
al
scharp
et
al
first
human
islet
allograft
perform
use
cadaver
islet
cell
najarian
et
al
howev
procedur
unsuccess
possibl
due
effect
immunosuppress
drug
decad
later
sharp
laci
perform
first
success
islet
cell
transplant
scharp
et
al
oper
patient
insulinindepend
almost
month
though
modest
achiev
result
nevertheless
posit
mileston
field
transplant
surgeon
jame
shapiro
specul
potenti
efficaci
islet
transplant
immunolog
barrier
resolv
articl
commemor
discoveri
insulin
comment
islet
transplant
could
function
entir
lifetim
patient
long
immunolog
damag
recurr
autoimmun
allograft
reject
prevent
patient
maintain
islet
function
longest
period
date
receiv
transplant
islet
total
pancreatectomi
univers
minnesota
year
ago
remain
insulin
independ
shapiro
islet
autotransplant
gener
perform
patient
chronic
pancreat
follow
oper
remov
pancrea
sinc
patient
requir
use
immunosuppress
drug
greater
likelihood
islet
surviv
thu
islet
function
retain
longer
period
context
islet
allograft
parallel
develop
islet
allotransplant
scientist
also
begun
experi
porcin
islet
centuri
watson
william
attempt
transplant
ovin
pancreat
tissu
research
reviv
xenotransplant
possibl
therapi
cure
diabet
condit
porcin
islet
sourc
fetal
neonat
adult
pig
sourc
pig
may
wildtyp
genet
modifi
pig
ideal
sourc
islet
cell
readili
avail
breed
quickli
produc
larg
litter
display
insulin
secret
pattern
compar
found
human
liu
harlan
porcin
insulin
use
treat
diabet
mani
decad
hyperacut
reject
pig
tissu
may
amelior
clone
genet
modif
though
pig
gener
prefer
sourc
anim
research
also
experi
islet
cell
speci
includ
cow
rabbit
fish
mihalicz
et
al
comparison
nonhuman
primat
pig
pose
less
diseas
risk
less
ethic
concern
sinc
lower
evolutionari
scale
boneva
folk
first
islet
xenotransplant
clinic
trial
perform
carlgustav
groth
former
chief
physician
transplant
surgeri
karolinska
univers
hospit
hudding
sweden
though
groth
first
conceiv
idea
perform
clinic
trial
groth
treat
ten
particip
islet
cell
porcin
foetus
groth
et
al
pig
cell
either
transplant
kidney
capsul
infus
intraport
vein
subsequ
kidney
biopsi
identifi
viabl
islet
cell
relat
hormon
call
glucagon
indic
insulin
secret
though
trial
lead
reduct
particip
insulin
requir
offer
valuabl
preliminari
data
graft
function
indic
long
term
surviv
porcin
cell
human
bodi
two
year
later
anoth
team
swedish
scientist
attempt
treat
two
dialysi
patient
anim
extern
therapi
patient
blood
circul
pig
kidney
hour
return
patient
bodi
hanson
groth
work
inspir
scientist
pursu
islet
xenograft
anim
experiment
clinic
trial
number
studi
demonstr
porcin
islet
xenotransplant
could
revers
diabet
nonhuman
primat
least
month
here
walawalkar
here
et
al
islet
xenotransplant
clinic
trial
also
conduct
sever
countri
includ
mexico
russia
china
new
zealand
argentina
trial
indic
islet
xenotransplant
reduc
requir
daili
dosag
insulin
incid
hypoglycaemia
torri
howev
countri
develop
islet
xentransplant
halt
sever
year
due
public
health
concern
regard
risk
infecti
diseas
next
section
address
global
public
controversi
xenotransplant
propos
moratorium
highrisk
research
earli
field
xenotransplant
revitalis
research
agenda
announc
first
transgen
pig
cambridg
england
connor
name
astrid
pig
produc
british
firm
imutran
astrid
engin
decayacceler
factor
hdaf
inhibit
immunolog
reject
porcin
organ
tissu
human
rosengard
et
al
two
year
later
imutran
announc
result
cardiac
xenograft
experi
monkey
two
ten
cynomologu
monkey
surviv
day
nativ
heart
replac
heart
transgen
pig
lauranc
guardian
news
welcom
biotechnolog
industri
posit
report
media
one
journalist
equat
imutran
achiev
signific
mileston
organ
transplant
declar
excit
breakthrough
sinc
first
heart
transplant
oper
perform
christian
barnard
palmer
perhap
unbeknown
journalist
barnard
also
perform
two
cardiac
xenotranspl
cape
town
south
africa
due
lack
avail
donor
heart
barnard
resort
heart
nonhuman
primat
bridg
initi
implant
baboon
heart
year
old
femal
patient
barnard
repeat
procedur
transplant
chimpanze
heart
year
old
male
patient
surviv
period
poor
case
h
day
respect
although
barnard
plan
continu
perform
xenotransplant
subsequ
abandon
idea
conced
becam
attach
chimpanze
cooper
lanza
consequ
posit
result
attain
imutran
compani
acquir
swiss
pharmaceut
corpor
sandoz
reuter
news
sandoz
intend
develop
xenotransplant
clinic
therapi
midnineti
xenotransplant
attract
consider
ventur
capit
toward
end
decad
persidi
report
total
compani
pursu
research
xenotransplant
persidi
solomon
brother
propos
appear
overli
optimist
financi
assess
research
claim
market
xenotransplant
could
worth
approxim
billion
biotechnolog
busi
news
anticip
possibl
clinic
trial
govern
agenc
ngo
began
consid
ethic
regul
xenotransplant
nuffield
council
bioethic
independ
british
chariti
conduct
first
public
inquiri
topic
march
issu
influenti
report
titl
animaltohuman
transplant
ethic
xenotransplant
council
report
conclud
ethic
accept
use
pig
organ
tissu
transplant
given
scarciti
human
biolog
materi
nuffield
council
bioethic
viii
adopt
precautionari
approach
xenotransplant
report
recommend
establish
advisori
committe
overse
monitor
xenotransplant
research
clinic
trial
accord
sobbrio
jorqui
nuffield
council
report
innov
sinc
first
attempt
appli
precautionari
principl
protect
public
health
beyond
field
environment
scienc
human
sobbrio
jorqui
follow
year
interdisciplinari
committe
appoint
uk
depart
health
put
forward
compar
report
commonli
known
kennedi
report
chairperson
sir
ian
kennedi
document
reiter
propos
made
nuffield
council
report
u
k
depart
health
follow
report
govern
promptli
set
uk
xenotransplant
interim
regulatori
author
ukxira
inter
alia
term
refer
ukxira
instruct
author
provid
advic
govern
safeti
efficaci
consider
anim
welfar
precondit
xenotransplant
human
use
whether
met
ukixra
march
shift
trajectori
xenotransplant
research
occur
lead
virologist
clive
patienc
colleagu
alert
scientist
gener
public
risk
infecti
diseas
associ
porcin
endogen
retrovirus
perv
endogen
retrovirus
found
genom
mammal
speci
sinc
porcin
retrovirus
embed
swine
genom
would
difficult
select
breed
pig
free
perv
pathogen
express
perv
dna
found
wide
rang
pig
organ
tissu
includ
liver
lung
kidney
heart
pancrea
skin
blood
endotheli
cell
bone
marrow
cell
follow
vitro
laboratori
experi
patienc
et
al
demonstr
human
cell
line
could
infect
two
strand
porcin
retrovirus
patienc
et
al
vitro
infect
necessarili
lead
vivo
infect
nevertheless
possibl
perv
infect
need
taken
serious
given
past
preced
animaltohuman
viral
transmiss
eg
rabi
ebola
monkey
pox
herp
viru
b
term
xenozoonosi
coin
refer
infecti
agent
introduc
human
xenogen
tissu
oconnel
et
al
result
vivo
perv
studi
catalys
public
debat
within
scientif
commun
beyond
ethic
conduct
research
pose
public
health
risk
follow
paper
patienc
et
al
fda
research
confirm
risk
crossspeci
infect
due
perv
similar
experi
wilson
et
al
consequ
fda
suspend
xenotransplant
studi
period
month
introduc
addit
regulatori
measur
clinic
trial
could
resum
investig
requir
revis
consent
form
introduc
surveil
procedur
screen
sourc
anim
monitor
recipi
possibl
perv
infect
bloom
public
debat
retrovir
risk
xenotransplant
becam
complic
vivo
studi
crossspeci
infect
posttransplant
perv
transmiss
infect
document
laboratori
anim
human
patient
exampl
diabet
immunocompromis
mice
infect
perv
follow
transplant
porcin
islet
cell
van
der
laan
et
al
august
swedish
scientist
publish
two
paper
lancet
perv
infect
found
blood
sampl
obtain
ten
diabet
undergon
islet
xenotransplant
henein
et
al
similarli
also
neg
result
perv
transmiss
involv
two
dialysi
patient
expos
procin
xenoperfus
patienc
et
al
follow
year
lack
perv
infect
also
confirm
larg
studi
patient
publish
scienc
paradi
et
al
studi
consist
patient
number
countri
undergon
differ
type
therapi
involv
use
anim
tissu
particip
receiv
porcin
islet
cell
treat
diabet
temporari
pig
skin
graft
treat
sever
burn
cohort
previous
particip
russian
xenoperfus
experi
assess
immunotherapi
paradi
et
al
due
clinic
result
author
studi
advoc
use
close
monitor
clinic
trail
evalu
efficaci
safeti
porcin
xenogen
therapi
paradi
et
al
howev
editori
comment
virologist
robin
weiss
urg
caution
given
natur
epidemiolog
research
argu
evid
risk
evid
risk
weiss
shortli
patienc
et
al
publish
research
result
fritz
bach
initi
call
nation
review
moratorium
xenotransplant
clinic
trial
bach
promin
transplant
immunologist
lewi
thoma
distinguish
professor
immunolog
surgeri
harvard
medic
school
notwithstand
strong
commit
xenograft
research
bach
argu
prematur
introduct
experiment
procedur
monaco
advoc
public
debat
input
determin
whether
justifi
undertak
research
notwithstand
inher
public
health
risk
bach
call
moratorium
ethic
question
could
resolv
view
ethic
issu
preced
technic
scientif
consider
bach
attract
support
advocaci
peer
assist
write
paper
eight
coauthor
bach
publish
paper
polici
approach
xenotransplant
research
natur
medicin
februari
bach
et
al
similarli
paper
written
ivinson
bach
pose
ethic
challeng
scientif
colleagu
ask
appli
principl
inform
consent
entir
commun
commun
whole
expos
risk
least
inform
repres
public
given
opportun
particip
activ
meaning
decis
whether
condit
societi
expos
risk
uneth
foist
particular
medic
risk
patient
equal
uneth
expos
public
risk
without
first
consid
opinion
bach
ivinson
bach
et
al
argu
moratorium
antisci
bach
et
al
rather
temporari
ban
xenotransplant
would
afford
public
opportun
particip
debat
word
way
respect
right
public
thu
preserv
trust
public
scienc
bach
et
al
propos
compar
requir
individu
particip
biomed
research
describ
form
societ
consent
bach
commun
consent
daar
social
inform
consent
persson
welin
inform
consent
relev
commun
forthcom
xenotransplant
clinic
trial
proceed
across
atlant
council
europ
unanim
adopt
recommend
legal
bind
moratorium
xenotransplant
clinic
trial
basi
precautionari
principl
council
europ
call
public
particip
alreadi
recommend
institut
medicin
report
xenotransplant
institut
medicin
howev
propos
put
forward
bach
colleagu
accept
us
david
sach
colleagu
wrote
letter
respons
sach
et
al
sach
paul
russel
professor
surgeri
immunolog
harvard
medic
school
director
transplant
biolog
research
center
massachusett
gener
hospit
sach
et
al
agre
bach
et
al
need
caution
howev
former
group
believ
local
institut
review
board
fda
could
adequ
carri
necessari
evalu
risk
assess
drug
test
sach
et
al
also
emphasis
xenotransplant
current
seen
promis
nearterm
solut
sever
shortag
human
tissu
organ
conven
new
nation
bodi
consid
ramif
would
undoubtedli
lead
unnecessari
delay
avoid
loss
life
sach
et
al
fda
align
posit
advoc
sach
colleagu
confer
conven
nation
institut
health
nih
januari
act
fda
commission
michael
friedman
state
request
moratorium
highli
valuabl
part
public
debat
ad
believ
import
set
framework
respons
conduct
research
wadman
fda
posit
consist
casebycas
approach
adopt
time
ukixra
einsiedel
et
al
argument
moratorium
xenotransplant
clinic
trial
attract
commentari
physician
us
europ
australia
daniel
salomon
et
al
speak
behalf
american
societi
transplant
physician
american
societi
transplant
surgeon
dismiss
propos
present
bach
et
al
best
opinion
minor
among
us
transplant
profession
salomon
et
al
believ
bach
et
al
overestim
infecti
risk
associ
xenotranspl
experi
hand
peter
collignon
infecti
diseas
expert
australia
went
even
view
nation
approach
inadequ
sinc
virus
necessarili
contain
politicojurid
border
argu
stringent
global
regul
xenotransplant
clinic
trial
uniform
enforc
control
procedur
collignon
warn
possibl
inadequ
regul
research
jurisdict
collignon
wrote
demand
organ
countri
less
stringent
regul
may
becom
haven
perform
less
regul
therefor
danger
xenotransplant
procedur
collignon
made
compel
argument
effect
regul
underscor
public
health
risk
xenotransplant
follow
collect
plan
futur
xenograft
transplant
creat
ideal
condit
anim
virus
infect
cross
speci
barrier
human
prolifer
xenotranspl
thu
repres
one
best
experi
could
devis
creat
new
infecti
agent
would
somewhat
paradox
main
legaci
modern
medicin
involv
transplant
anoth
infect
hiv
collignon
due
global
dimens
public
health
risk
world
health
organis
becam
involv
xenotransplant
research
adopt
proactiv
role
noel
sinc
first
meet
octob
work
intern
xenotransplant
associ
ixa
issu
seri
guidanc
document
prevent
manag
infecti
diseas
context
clinic
xenotransplant
daar
noel
collabor
univers
hospit
geneva
ixa
also
establish
websit
document
xenotransplant
clinic
trial
around
world
thu
far
websit
inventori
human
xenotransplant
practic
collect
data
clinic
inventori
indic
xenograft
experi
perform
europ
north
america
africa
asia
pacif
event
unfold
concern
rais
collignon
becam
prescient
controversi
ensu
clinic
trial
conduct
dr
rafael
vald
gonzalez
frederico
gomez
children
hospit
mexico
mexico
citi
vald
collabor
research
canada
new
zealand
sinc
treat
least
minor
type
diabet
includ
two
canadian
neonat
porcin
islet
sertoli
cell
armstrong
cell
place
collagen
coat
devic
subcutan
implant
abdomen
islet
cell
combin
sertoli
cell
sinc
believ
latter
induc
immunolog
toler
studi
sought
build
upon
work
groth
et
al
undertaken
previou
decad
vald
et
al
claim
clinic
trial
produc
promis
result
two
patient
becom
insulinindepend
sever
month
half
cohort
experienc
signific
reduct
insulin
requir
et
al
howev
upon
public
announc
studi
scientif
confer
trial
attract
strong
public
critic
ixa
member
mckenzi
et
al
prolong
disput
took
place
vald
ixa
scientist
vald
syke
et
al
valdesgonzalez
due
pressur
intern
scientif
commun
mexican
xenotransplant
eventu
termin
local
govern
author
contrast
vald
practic
xenotransplant
clinic
trial
outsourc
new
zealand
compani
research
institut
moscow
contest
scientif
commun
trial
voluntarili
adher
guidelin
issu
fda
includ
provis
surveil
risk
manag
infecti
agent
cook
et
al
follow
controversi
xenotour
mexico
world
health
assembl
wha
adopt
resolut
human
organ
tissu
transplant
may
wha
resolut
pass
countri
urg
member
state
allow
xenogen
transplant
effect
nation
regulatori
control
surveil
mechan
overseen
nation
health
author
place
fiftyseventh
wha
claus
ii
xenotransplant
clinic
trial
permiss
countri
welldevelop
regulatori
framework
overse
highrisk
biomed
research
absenc
stringent
regul
clinic
xenotransplant
would
pose
global
public
health
risk
addit
wha
resolut
also
advis
member
state
engag
harmonis
regulatori
practic
support
intern
collabor
coordin
prevent
surveil
infect
result
xenogen
transplant
fiftyseventh
wha
claus
ii
consist
global
approach
permiss
law
xenotransplant
enact
switzerland
griessler
xenotransplant
permit
subject
prior
authoris
due
complianc
regulatori
requir
swiss
interest
xenotransplant
link
commerci
invest
research
made
norvati
formerli
sandoz
hand
xenotransplant
research
also
contest
polit
parti
ngo
includ
green
parti
social
democrat
parti
basel
appeal
genet
engin
greenpeac
switzerland
physician
anim
experiment
swiss
anim
protect
local
public
debat
xenotransplant
began
accord
griessler
debat
neither
extens
continu
concern
small
group
inform
actor
research
parliament
public
administr
stakehold
organ
griessler
divers
rang
view
xenotransplant
canvass
feder
parliamentari
debat
though
propos
bill
ban
procedur
introduc
swiss
parliament
defeat
toward
end
follow
year
publiforum
consensu
confer
transplant
major
lay
particip
affirm
support
xenotransplant
research
griessler
notwithstand
public
object
xenotransplant
among
section
commun
introduct
permiss
law
sought
protect
local
research
econom
interest
swiss
pharmaceut
industri
conflict
global
scienc
local
concern
regard
public
health
patient
safeti
taken
place
part
world
foreshadow
explor
compar
develop
canada
australia
follow
two
subsect
paper
though
bach
abl
substant
influenc
polici
discours
us
across
border
februari
canadian
broadcast
corpor
host
debat
bach
daniel
salomon
nation
bach
also
coauthor
paper
canadian
medic
associ
journal
neurologist
adrian
ivinson
ivinson
bach
explain
argument
public
particip
draw
analog
controversi
genet
modifi
food
refer
hendrik
verfail
presid
monsanto
pledg
new
compani
varfail
state
thought
great
thing
lot
peopl
thought
make
mistak
blind
enthusiasm
miss
fact
technolog
rais
major
issu
ethic
choic
trust
even
democraci
global
tri
understand
happen
realiz
need
hear
directli
peopl
thought
concern
thought
ought
close
gap
believ
benefit
concern
someth
chang
ivinson
bach
bach
ivinson
given
comment
bach
ivinson
argu
public
consult
ethic
approach
sound
busi
practic
call
meaning
public
engag
taken
particularli
serious
canada
long
tradit
public
consult
policymak
einsiedel
et
al
context
nation
scienc
polici
canadian
scholar
einsiedel
colleagu
posit
countri
us
europ
einsiedel
et
al
lack
polaris
view
canada
compar
jurisdict
consist
moder
approach
genet
modifi
food
canadian
stakehold
group
anim
tend
advoc
anim
welfar
rather
anim
right
us
regulatori
style
defin
adversari
cultur
wherebi
stakehold
tend
reli
judici
system
pursu
claim
interest
einsiedel
et
al
demonstr
legal
suit
file
campaign
respons
transplant
crt
crt
establish
alix
fano
new
york
oppos
form
xenotransplant
crt
taken
legal
action
fda
contest
appoint
committe
member
secretari
advisori
committe
xenotransplant
sacx
bickford
et
al
sacx
set
depart
health
human
servic
review
xenotransplant
polici
us
fano
maintain
major
committe
member
scientist
vest
interest
xenotransplant
henc
describ
activ
sacx
case
fox
guard
hen
hous
allspaw
similarli
uk
practic
xenotransplant
contest
anim
right
group
uncag
septemb
uncag
publish
seri
articl
draw
upon
leak
document
oper
huntingdon
life
scienc
cambridg
einsiedel
et
al
huntingdon
contract
perform
xenotransplant
experi
behalf
imutran
leak
document
expos
breach
laboratori
standard
undu
suffer
anim
inaccur
report
scientif
result
imutran
attempt
secur
injunct
restrain
public
made
uncag
unsuccess
subsequ
imutran
termin
research
activ
uk
reloc
work
anim
laboratori
us
einsiedel
et
al
contrast
us
uk
canadian
approach
emphas
collabor
represent
commun
consult
key
process
achiev
public
consensu
addit
xenotransplant
issu
also
shape
preced
controversi
concern
contamin
canadian
blood
suppli
consequ
administr
took
extra
precaut
pursu
proactiv
stanc
risk
manag
transplant
past
einsiedel
et
al
toward
end
health
canada
appoint
expert
advisori
committe
conven
nation
forum
xenotransplant
jurisdict
committe
compris
expert
biomed
social
scienc
includ
surgeon
veterinarian
virologist
lawyer
philosoph
forum
address
clinic
regulatori
ethic
aspect
xenotransplant
recommend
public
must
involv
stage
discuss
issu
perspect
incorpor
decisionmak
einsiedel
et
al
consequ
plan
workshop
held
april
design
process
public
consult
stakehold
follow
workshop
health
canada
engag
canadian
public
health
associ
cpha
organis
armslength
public
consult
turn
cpha
hire
public
advisori
group
pag
carri
public
consult
einsiedel
et
al
prior
work
pag
propos
canadian
standard
xenotransplant
issu
public
comment
propos
standard
written
member
expert
advisori
committe
intend
regul
xenotransplant
clinic
trial
canada
pag
commenc
process
public
engag
educ
awar
program
given
canadian
draft
standard
xenotransplant
public
consult
focus
one
overarch
question
health
canada
proceed
xenotransplant
condit
einsiedel
et
al
pag
sought
public
input
two
approach
open
model
ii
repres
model
einsiedel
et
al
first
approach
survey
public
opinion
differ
mode
commun
includ
websit
questionnair
stakehold
mail
survey
inform
feedback
letter
email
second
base
larg
telephon
poll
seri
citizen
juri
citizen
fora
total
canadian
particip
telephon
survey
involv
answer
question
einsiedel
et
al
pag
held
six
forum
region
site
across
countri
similarli
telephon
poll
invit
attend
citizen
forum
base
random
sampl
process
select
particip
determin
mainli
demograph
two
half
day
total
particip
attend
present
given
expert
differ
aspect
xenotransplant
expert
panel
compris
expert
field
transplant
infecti
diseas
law
bioethic
anim
welfar
consum
health
particip
opportun
pose
question
present
discuss
matter
among
data
citizen
juri
obtain
proceed
particip
survey
pag
conclud
particip
provid
inform
greater
likelihood
would
oppos
xenotransplant
follow
public
consult
pag
prepar
report
put
forward
seven
recommend
first
recommend
advis
canada
proceed
xenotransplant
clinic
trial
report
conclud
major
inform
canadian
support
xenotransplant
time
cpha
vi
pag
explain
outcom
mean
inform
canadian
absolut
oppos
xenotransplant
howev
favour
precautionari
approach
cpha
report
also
identifi
number
critic
issu
yet
resolv
includ
potenti
health
risk
lack
preclin
knowledg
unexplor
altern
therapi
inadequaci
exist
regul
govern
xenotransplant
clinic
trial
cpha
vi
canadian
govern
yet
issu
offici
polici
xenotransplant
beynonjon
brown
time
health
canada
revis
updat
standard
clinic
einsiedel
et
al
suggest
delay
updat
standard
could
interpret
adopt
de
facto
moratorium
einsiedel
et
al
canadian
standard
xenotransplant
consist
intern
guidelin
includ
wha
resolut
canadian
nation
inquiri
initi
scientist
indic
intent
submit
applic
conduct
clinic
trial
involv
use
porcin
cell
thu
far
trial
taken
place
canada
einsiedel
et
al
canadian
public
consult
xenotransplant
novel
social
experi
commun
engag
complex
technosci
einsiedel
et
al
note
first
extens
delib
consult
undertaken
health
canada
einsiedel
et
al
interview
member
canadian
public
servic
jone
einsiedel
found
xenotransplant
consult
contribut
learn
public
engag
health
canada
routin
close
expertdriven
regulatori
practic
destabilis
health
canada
gone
develop
inhous
infrastructur
expertis
public
engag
jone
einsiedel
regard
xenotransplant
controversi
enhanc
open
transpar
canadian
health
care
administr
though
xenotransplant
consult
welcom
posit
develop
social
scientist
contrari
respons
present
one
biomed
scientist
jame
r
wright
express
discont
pag
consult
paper
publish
three
promin
biomed
journal
transplant
xenotransplant
canadian
medic
associ
journal
cmaj
wright
wright
jr
describ
xenotransplant
research
member
canadian
xenotransplant
expert
work
group
wright
identifi
consid
three
seriou
problem
canadian
public
consult
firstli
pag
fail
distinguish
differ
type
xenotransplant
carri
differ
level
associ
public
health
person
risk
wright
wright
jr
argu
tailor
polici
respons
prefer
blanket
prohibit
xenotransplant
clinic
trial
acknowledg
whole
organ
xenotransplant
prematur
support
clinic
experiment
cellular
therapi
diabet
patient
parkinson
diseas
ii
ex
vivo
perfus
transgen
pig
liver
patient
termin
liver
failur
without
liver
donor
wright
secondli
wright
claim
defect
anomali
procedur
process
adopt
pag
argu
overarch
question
vagu
consider
variabl
outcom
citizen
forum
suggest
influenc
expert
deliber
wright
queri
suitabl
expert
appoint
make
present
citizen
juri
wright
wright
wright
addit
highli
critic
lack
inform
provid
forum
particip
canadian
standard
person
find
fifth
recommend
bothersom
stringent
regul
develop
cover
aspect
xenotransplant
clinic
trial
regulatori
framework
alreadi
exist
public
advisori
group
summar
propos
canadian
standard
layperson
term
present
consid
vote
qualifi
ie
yet
one
major
concern
express
public
concern
develop
appropri
regul
result
expens
exercis
valid
key
inform
withheld
sure
whole
object
exercis
educ
panellist
ask
vote
wright
subsequ
paper
wright
specul
possibl
reason
exclus
canadian
standard
provis
inform
forum
particip
standard
could
taken
impli
decis
proceed
made
organis
attempt
keep
exercis
nondirect
wright
thirdli
wright
jr
assert
sever
flaw
process
public
consult
compound
overinterpret
data
wright
view
citizen
panelist
vote
qualifi
possibl
futur
could
reinterpret
yet
cpha
wright
comb
yet
qualifi
ye
ye
condit
give
total
particip
support
xenotransplant
base
analysi
data
wright
jr
argu
approxim
twothird
meaning
inform
canadian
support
xenotransplant
possibl
futur
treatment
safeti
efficaci
demonstr
wright
wright
decri
separ
qualifi
ye
qualifi
blatantli
invalid
wright
howev
argument
pose
wright
jr
entir
new
rais
relat
earlier
discuss
result
australian
survey
patient
attitud
toward
xenotransplant
instanc
mohacsi
et
al
respond
critic
scienc
remind
reader
data
disput
mere
interpret
mohacsi
et
al
exchang
wright
social
scientist
public
opinion
data
aptli
describ
war
public
tallachini
addit
critic
wright
also
affirm
support
public
consult
summaris
consid
problemat
canadian
respons
follow
canadian
public
health
associ
went
wrong
attempt
design
consult
analyz
result
make
recommend
entir
arm
length
none
author
person
knowledg
xenotransplant
thu
member
miss
flaw
process
interpret
readili
appar
someon
knowledg
field
wright
point
opportun
feedback
stark
contrast
expert
work
group
standard
went
draft
review
committe
member
multipl
expert
variou
interest
group
approxim
year
offici
releas
wright
conclud
whether
clinic
trial
proceed
decis
expert
rather
public
view
public
decid
whether
form
therapi
would
potenti
like
avail
point
futur
wright
bach
ivinson
respond
argu
public
engag
equat
referendum
challeng
find
way
incorpor
public
voic
process
construct
public
polici
ivinson
bach
though
wright
agre
respons
made
bach
ivinson
also
reiter
accuraci
interpret
data
believ
canadian
consult
use
correct
analysi
show
consider
support
concept
wright
australian
xenotransplant
inquiri
commenc
long
canadian
public
consult
conclud
see
wright
comment
influenc
aspect
approach
design
australian
inquiri
march
journalist
deborah
smith
wrote
articl
sydney
morn
herald
titl
pigtissu
transplant
given
green
light
smith
articl
focus
local
studi
led
berni
tuch
professor
medicin
univers
new
south
wale
unsw
tuch
colleagu
base
princ
wale
hospit
sydney
obtain
approv
ethic
committ
southeastern
sydney
area
health
servic
sesah
conduct
small
pilot
studi
involv
use
pig
islet
treat
diabet
cell
obtain
special
herd
pig
screen
ensur
cell
free
pathogen
smith
tuch
colleagu
demonstr
pig
cell
could
normalis
blood
glucos
diabet
pig
two
day
later
howev
smith
provid
updat
studi
unfold
controversi
ron
pirola
chairman
sesah
ethic
committe
disclos
committe
spent
year
deliber
unsw
applic
smith
note
nhmrc
notifi
throughout
process
ethic
review
risk
manag
strategi
adopt
close
monitor
patient
trial
began
bernadett
tobin
director
john
plunkett
centr
ethic
health
care
sydney
member
australian
health
ethic
committe
ahec
call
question
safeti
efficaci
trial
argu
research
ethic
matter
signific
commun
peopl
benefit
research
smith
similarli
local
oversea
virologist
warn
risk
crossspeci
infect
peter
collignon
infecti
diseas
physician
canberra
hospit
comment
theoret
major
public
health
risk
propos
trial
halt
least
australia
nation
safeti
guidelin
anim
tissu
transplant
place
smith
midaugust
unsw
studi
suspend
macey
nhmrc
refer
matter
one
expert
committe
gene
relat
therapi
research
advisori
panel
gtrap
asid
provid
advic
clinic
trial
involv
gene
therapi
role
gtrap
expand
includ
xenotransplant
two
expert
xenotransplant
one
expert
infecti
diseas
appoint
gtrap
panel
nhmrc
chair
gtrap
ron
trent
professor
medicin
univers
sydney
trent
inform
media
liais
tuch
studi
suspend
conduct
discuss
seah
ethic
committe
state
concern
safeti
issu
discuss
safeti
issu
still
total
clear
moment
studi
hold
macey
decis
nhmrc
interven
coincid
decis
termin
xenotransplant
program
conduct
edinburgh
august
scottish
media
report
geron
biom
ltd
halt
fund
geneticallymodifi
pig
experi
carri
roslin
institut
decis
motiv
concern
potenti
retrovir
infect
peterkin
shortli
thereaft
risk
perv
infect
underscor
result
mice
studi
publish
natur
editor
report
research
scripp
research
institut
california
demonstr
transplant
pig
pancreat
islet
immunosuppress
mice
lead
widespread
infect
perv
editori
follow
month
trent
made
anoth
public
statement
clarifi
statu
unsw
xenotransplant
studi
studi
remain
hold
nation
public
consult
trent
inform
journalist
ahec
due
discuss
matter
australian
would
get
say
animaltohuman
transplant
trial
allow
announc
rous
public
consult
would
take
place
gtrap
prepar
draft
guidelin
xenotransplant
research
trent
state
parallel
process
forc
us
basic
go
studi
conduct
like
say
trial
goe
ahead
knew
ahec
happi
ahec
make
sure
commun
happi
rous
day
tuch
report
result
month
mice
studi
concern
perv
infect
interview
journalist
remark
found
insulinproduc
pig
cell
transplant
mice
immun
system
pig
retrovirus
infect
rous
howev
also
conced
addit
biosafeti
studi
necessari
document
subsequ
publish
nhmrc
appear
gtrap
review
propos
unsw
studi
recommend
proceed
reason
provid
includ
lack
evid
benefit
patient
unquantifi
potenti
commun
risk
concern
biolog
safeti
sourc
materi
nhmrc
addit
nhmrc
also
requir
therapeut
trial
nonhuman
primat
human
clinic
trial
could
proceed
decemb
nhmrc
complet
necessari
administr
set
xenotransplant
work
parti
xwp
establish
xwp
initi
ahec
research
committe
work
parti
held
first
meet
earli
seven
member
xwp
drawn
nhmrc
council
variou
committe
includ
ahec
gtrap
research
committe
anim
welfar
committe
consum
health
forum
xwp
term
refer
instruct
xwp
provid
advic
scientif
ethic
technic
issu
relat
xenotransplant
research
produc
guidelin
assess
animaltohuman
transplant
trial
propos
consult
wide
commun
issu
xwp
iii
contrast
canadian
respons
public
consult
separ
process
draft
review
guidelin
xenotransplant
clinic
trial
kerri
breen
initi
chairperson
work
parti
compar
consult
process
public
inform
risk
sign
commun
consent
form
mathewson
breen
colleagu
xwp
bernadett
tobin
queri
whether
obtain
public
consensu
possibl
observ
number
pretti
formid
ethic
concern
allow
futur
trial
go
ahead
skatsson
anthoni
apic
director
immunolog
research
st
vincent
hospit
melbourn
vice
presid
ixa
welcom
public
consult
thing
good
us
remark
one
certain
way
kill
scienc
infanc
would
disast
wroe
xwp
conduct
two
round
public
consult
undertak
first
round
consult
work
parti
publish
document
titl
draft
guidelin
discuss
paper
xenotransplant
juli
state
aim
discuss
paper
provis
inform
xenotransplant
facilit
open
frank
debat
xwp
draft
guidelin
xwp
propos
list
criteria
principl
met
xenotransplant
clinic
trial
could
proceed
propos
research
must
serv
common
good
justifi
risk
scientif
sound
therapeut
design
protect
safeti
right
close
contact
ensur
longterm
monitor
particip
facilit
adequ
inform
voluntari
consent
xwp
work
parti
conduct
initi
consult
invit
written
submiss
host
meet
four
capit
citi
xwp
receiv
written
submiss
total
particip
attend
public
meet
held
sydney
melbourn
perth
two
target
meet
held
perth
adelaid
total
invit
particip
xwp
respond
support
xwp
draft
guidelin
major
respond
state
oppos
animaltohuman
transplant
xwp
para
main
counterargu
includ
risk
infect
transplant
recipi
entir
commun
violat
anim
right
fund
resourc
could
better
direct
elsewher
doubt
likelihood
patient
benefit
xwp
para
lawrenc
pope
presid
victorian
anim
welfar
associ
made
scath
comment
media
appal
abus
anim
said
centuri
member
public
want
govern
brightest
mind
assist
anim
come
new
way
torment
tortur
barri
interview
journalist
peter
collignon
note
draft
guidelin
issu
presumpt
xenotransplant
accept
notwithstand
public
health
risk
similarli
bach
emphas
import
public
consult
strong
commun
discuss
agreement
whether
process
boog
unlik
canadian
consult
question
pose
australian
public
xenotransplant
proceed
rather
offer
opportun
comment
australia
proceed
xenotransplant
xwp
written
oral
respons
individu
organis
feed
back
design
second
round
public
consult
xwp
acknowledg
submiss
discuss
public
meet
rais
mani
signific
concern
identifi
issu
fulli
cover
discuss
paper
need
consider
discuss
xwp
para
xwp
report
two
shortcom
initi
consult
mani
particip
consid
solid
organ
xenotransplant
ii
particip
repres
interest
group
xwp
para
note
submiss
transplant
recipi
patient
may
benefit
xenogen
therapi
xwp
para
second
consult
xwp
engag
servic
public
relat
compani
promot
commun
engag
increas
public
particip
xwp
also
expand
includ
new
member
expertis
anim
welfar
clinic
trial
regul
manag
infecti
diseas
xwp
para
anim
issu
subcommitte
ai
form
address
issu
anim
ethic
anim
welfar
use
anim
experiment
transplant
xwp
para
term
refer
xwp
redraft
minor
modif
xwp
para
separ
term
refer
prepar
ai
xwp
para
earli
xwp
ai
issu
two
document
undertak
second
round
nation
consult
plain
english
guid
xenotransplant
prepar
provid
access
inform
gener
public
xwp
xwp
set
respons
initi
consult
second
discuss
paper
xwp
though
work
parti
acknowledg
xenotransplant
highli
contest
conclud
signific
inprincipl
ethic
object
use
live
organ
tissu
anim
human
therapi
would
preclud
research
develop
therapi
emphasi
origin
xwp
para
reiter
posit
adopt
previou
consult
xenotransplant
clinic
trial
allow
proceed
clear
potenti
benefit
individu
patient
gener
public
xwp
para
draft
guidelin
revis
incorpor
two
new
topic
anim
welfar
patient
select
addit
guidelin
requir
research
protocol
specifi
clear
inform
criteria
patient
select
propos
guidelin
xwp
accord
relev
regul
preclin
clinic
xenotransplant
studi
requir
meet
rigor
anim
welfar
standard
propos
guidelin
xwp
similarli
initi
consult
second
round
consult
involv
public
meet
call
written
submiss
februari
xwp
held
public
meet
capit
citi
around
countri
attract
total
attende
occas
target
meet
second
round
meet
jack
sparrow
second
chairperson
xwp
made
gener
comment
public
respons
interview
nation
radio
sparrow
report
transplant
recipi
patient
wait
list
famili
support
xenotransplant
beaumont
nobl
howev
also
ad
australian
fear
use
live
anim
materi
human
month
ago
result
sever
acut
respiratori
syndrom
bird
flu
outbreak
oversea
reuter
news
work
parti
receiv
total
written
submiss
respond
australia
oversea
xwp
public
consult
xwp
found
animaltohuman
transplant
particular
anim
organ
transplant
accept
mani
peopl
xwp
vii
interest
group
ad
debat
publish
contradictori
outcom
two
separ
public
opinion
survey
conduct
poll
commiss
pfizer
australia
transplant
found
respond
would
accept
organ
anim
lifeordeath
situat
wood
studi
survey
peopl
state
territori
anderson
hand
australian
associ
human
research
aahr
present
contrari
perspect
base
outcom
newspol
survey
commiss
newspol
interview
adult
late
may
survey
reveal
interviewe
knew
xenotransplant
think
process
approv
clinic
trial
mercuri
aahr
report
three
common
reason
oppos
xenotransplant
includ
belief
uneth
human
anim
differ
danger
human
health
aahr
given
lack
public
awar
xenotransplan
aahr
conclud
educ
campaign
conduct
xwp
ineffect
approv
xenotransplant
clinic
trial
would
place
australian
public
risk
without
knowledg
inform
consent
aahr
septemb
xwp
submit
final
report
propos
clinic
guidelin
animaltohuman
transplant
research
nhmrc
council
council
examin
debat
content
document
two
meet
initi
xwp
oppos
moratorium
type
animaltohuman
clinic
trial
includ
solid
xenotranspl
xwp
howev
end
inquiri
xwp
modifi
polici
final
report
xwp
advis
aot
anim
organ
transplant
trial
consid
least
next
year
basi
theoret
concern
suggest
type
transplant
carri
greatest
risk
infect
current
evid
indic
risk
outweigh
like
prospect
success
high
level
public
concern
anim
welfar
anim
involv
type
research
xwp
session
nhmrc
council
adopt
two
recommend
propos
work
parti
septemb
issu
communiqu
announc
would
year
ban
whole
organ
animaltohuman
transplant
ii
use
nonhuman
primat
eg
baboon
sourc
anim
clinic
transplant
nation
health
medic
research
council
nhmrc
latter
polici
consist
recommend
propos
nuffield
council
report
nuffield
council
bioethic
viii
nhmrc
council
explain
reach
decis
take
account
commun
concern
rais
two
round
nation
consult
includ
fear
new
infecti
diseas
transfer
anim
human
ethic
social
concern
use
welfar
anim
nation
health
medic
research
council
nhmrc
session
nhmrc
council
declin
endors
final
report
draft
guidelin
xwp
propos
establish
nation
committe
overse
research
anim
cell
therapi
anim
extern
therapi
compar
ukixra
xenotransplant
work
parti
xwp
also
recommend
cellular
extern
xenogen
therapi
given
extrem
cautiou
green
light
trial
strictli
regul
australia
howev
respons
propos
council
decid
otherwis
subsequ
communiqu
council
declar
clinic
trial
australia
use
anim
cellular
therapi
anim
therapi
year
nation
health
medic
research
council
nhmrc
followup
media
releas
issu
march
nhmrc
council
explain
decis
ban
form
xenotransplant
made
basi
risk
transmiss
anim
virus
transplant
recipi
wider
commun
adequ
resolv
addit
xenotransplant
research
earli
stage
clinic
trial
forese
futur
unlik
signific
benefit
research
particip
nation
health
medic
research
council
nhmrc
except
moratorium
appear
establish
practic
cultur
human
skin
tissu
feeder
layer
irradi
mous
cell
treat
burn
patient
nation
health
medic
research
council
nhmrc
council
also
instruct
gtrap
monitor
develop
field
provid
updat
council
state
would
reconsid
posit
new
inform
becam
avail
nation
health
medic
research
council
nhmrc
direct
council
final
report
draft
guidelin
made
public
endors
australian
xenotransplant
moratorium
implement
toward
end
stage
moratorium
nhmrc
council
revisit
issu
consid
futur
direct
xenotransplant
research
australia
media
releas
issu
decemb
michael
good
chairperson
nhmrc
council
state
care
consider
council
view
although
wide
rang
commun
view
topic
xenotransplant
research
accept
australia
robust
regul
place
nation
health
medic
research
council
nhmrc
nhmrc
indic
would
develop
guidanc
document
research
ethic
committe
base
advic
ahec
anim
welfar
committe
announc
welcom
research
jdrf
australia
live
cell
technolog
ltd
lct
privat
research
compani
base
new
zealand
immedi
issu
media
releas
express
intent
expand
xenotransplant
clinic
trial
australia
live
cell
technolog
time
lct
resum
xenotransplant
clinic
trial
new
zealand
new
zealand
moratorium
clinic
xenotransplant
lift
decemb
wherea
public
consult
key
aspect
australian
nation
inquiri
xenotransplant
decis
lift
moratorium
involv
input
australia
public
decis
call
question
critic
aahr
issu
media
releas
call
public
debat
maintain
commun
decis
necessari
sinc
gener
public
pay
ultim
penalti
fallout
australian
associ
human
research
sociologist
peta
cook
note
form
ctxtp
clinic
xenotransplant
theoret
possibl
australia
subject
ethic
approv
cook
argu
public
marginalis
divers
knowledg
devalu
public
consult
conduct
xwp
facilit
meaning
public
engag
cook
time
howev
also
acknowledg
public
input
bear
govern
decisionmak
cook
wrote
decis
ie
place
moratorium
form
clinic
xenotransplant
inform
commun
concern
scientif
uncertainti
surround
zoonosi
social
anxieti
regard
anim
welfar
use
outcom
suggest
nhmrc
respect
commun
issu
rais
lift
moratorium
decemb
suggest
otherwis
cook
final
report
xwp
propos
review
recommend
guidelin
year
period
specif
prescrib
review
must
includ
public
consult
xenotransplant
work
parti
xwp
viii
howev
extent
report
endors
statu
long
term
direct
ambigu
recent
nhmrc
decis
permit
clinic
xenotransplatant
align
polici
canada
new
zealand
unit
state
european
union
australian
guidelin
research
appear
avail
onlin
webpag
xenotransplant
research
nhmrc
state
issu
use
advic
australian
health
ethic
committe
anim
welfar
committe
guidanc
research
ethic
committe
involv
anim
human
studi
howev
document
webpag
archiv
public
made
avail
histor
purpos
support
decis
lift
nation
ban
nhmrc
publish
peerreview
discuss
paper
titl
xenotransplant
review
paramet
risk
benefit
nation
health
medic
research
council
nhmrc
paper
base
expert
consult
involv
nhmrc
staff
invit
guest
august
nhmrc
held
workshop
head
offic
canberra
review
xenotransplant
research
australia
workshop
attend
expert
australia
new
zealand
europ
us
nation
health
medic
research
council
nhmrc
though
australian
moratorium
intend
imped
preclin
xenotransplant
research
discuss
paper
note
unanticip
advers
consequ
moratorium
delay
develop
regulatori
guidelin
research
infrastructur
build
contain
facil
sourc
pig
nation
health
medic
research
council
nhmrc
discuss
paper
conclud
consensu
risk
pose
anim
virus
low
manag
via
herd
select
screen
strategi
provid
regulatori
mechan
oblig
complianc
realiti
risk
novel
infect
like
greater
allotransplant
compar
xenotransplant
human
donor
screen
held
specialis
contain
facil
nation
health
medic
research
council
nhmrc
word
pig
husbandri
allow
routin
test
known
pathogen
conduct
human
organ
donor
nhmrc
argu
xenograft
may
safer
allograft
nation
health
medic
research
council
nhmrc
discuss
paper
also
mention
xenogen
tissu
appear
rel
resist
infect
human
pathogen
commonli
complic
allotransplant
includ
hiv
hepat
virus
nhmrc
moreov
xenotransplant
present
potenti
superior
therapi
numer
advantag
allotransplant
includ
virtual
unlimit
suppli
tissu
flexibl
time
transplant
procedur
limit
requir
immunosuppress
nation
health
medic
research
council
nhmrc
nhmrc
discuss
paper
howev
omit
critic
discuss
limit
preclin
screen
sourc
pig
matter
alreadi
rais
two
decad
ago
referenc
comment
virologist
jonathan
allan
hanson
wrote
test
screen
unknown
monitor
patient
sourc
pig
tell
epidem
origin
hanson
altern
put
screen
prevent
outbreak
contagion
effect
test
known
diseas
agent
develop
incorpor
routin
surveil
procedur
shortcom
exist
risk
manag
strategi
alreadi
demonstr
allotransplant
elabor
limit
current
screen
practic
turn
consid
incid
involv
experiment
routin
allograft
final
part
paper
public
debat
xenotransplant
took
place
differ
part
world
scientist
achiev
signific
progress
research
transplant
human
islet
cell
jame
shapiro
colleagu
reinvigor
field
islet
transplant
announc
posit
result
studi
involv
seven
type
diabet
patient
shapiro
professor
surgeri
medicin
surgic
oncolog
director
clinic
islet
transplant
program
univers
alberta
subsequ
call
edmonton
protocol
approach
introduc
steroidfre
immunosuppress
regim
coupl
implant
larg
number
islet
multipl
donor
shapiro
et
al
protocol
attract
worldwid
interest
transform
islet
transplant
viabl
clinic
procedur
chisholm
et
al
summaris
key
find
edmonton
studi
follow
independ
insulin
inject
initi
achiev
patient
year
posttranspl
signific
reduct
hypoglycaemia
unawar
five
year
islet
transplant
major
patient
around
cpeptid
present
indic
insulin
product
minor
around
maintain
insulin
independ
resum
insulin
therapi
requir
half
pretranspl
insulin
dose
hypoglycaem
score
improv
significantli
posttranspl
maintain
year
fifti
percent
patient
demonstr
stabilis
improv
diabet
neuropathi
recent
long
term
follow
confirm
transplant
recipi
also
report
significantli
increas
qualiti
life
chisholm
et
al
discuss
part
islet
allograft
gener
restrict
patient
brittl
sever
diabet
patient
seek
treatment
need
demonstr
poor
qualiti
life
risk
health
complic
exceed
danger
associ
islet
transplant
due
outcom
edmonton
studi
field
islet
transplant
attract
consider
public
privat
money
first
major
initi
immun
toler
network
itn
fund
jdrf
intern
nation
institut
diabet
digest
kidney
diseas
niddk
nation
institut
allergi
infecti
diseas
niaid
program
receiv
us
million
begin
research
activ
associ
press
newswir
aim
itn
develop
new
immun
toler
therapi
juli
us
presid
bill
clinton
launch
first
intern
multicentr
studi
fund
itn
studi
involv
nine
research
centr
locat
us
canada
europ
robert
goldstein
chief
scientif
offic
jdrf
comment
itn
intellectu
powerhous
excit
see
mani
worldlead
work
togeth
singl
goal
mind
associ
press
newswir
four
year
later
annual
meet
american
diabet
associ
florida
shapiro
announc
outcom
itn
studi
report
approxim
half
cohort
particip
continu
insulinindepend
year
posttranspl
biotech
week
posit
result
offer
encourag
research
continu
investig
follow
itn
multicentr
studi
niddk
niaid
establish
clinic
islet
transplant
consortium
citc
citc
compris
network
research
centr
us
canada
norway
sweden
year
program
alloc
us
million
nation
institut
health
nih
studi
conduct
consortium
aim
improv
safeti
longterm
function
islet
consequ
intens
research
activ
research
abl
significantli
improv
efficaci
islet
transplant
schulz
diabet
institut
univers
minnesota
obtain
one
best
clinic
outcom
report
transplant
recipi
protect
hypoglycemia
immedi
transplant
remain
protect
sever
hypoglycemia
year
posttranspl
becom
insulin
independ
maintain
insulin
independ
year
posttranspl
schulz
diabet
institut
multiyear
multicentr
clinic
trial
conduct
citc
complet
spring
outcom
trail
began
report
peerreview
journal
ricordi
et
al
base
result
us
research
process
seek
approv
fda
provid
islet
transplant
clinic
therapi
anticip
approv
may
forthcom
near
futur
australia
compar
research
initi
establish
call
australian
islet
transplant
program
aitp
juvenil
diabet
research
foundat
jdrf
aitp
collabor
commonwealth
depart
health
age
jdrf
australia
program
receiv
initi
alloc
million
recent
april
feder
victorian
govern
provid
addit
fund
aitp
grant
nation
fund
centr
statu
aitp
link
research
centr
three
clinic
site
includ
westmead
hospit
sydney
st
vincent
hospit
svh
melbourn
queen
elizabeth
hospit
adelaid
thu
far
least
patient
receiv
total
transplant
edman
newslett
st
vincent
institut
medic
research
aitp
focus
develop
immunosuppress
protocol
protect
graft
tissu
minimis
renal
impair
consist
oversea
studi
data
aitp
confirm
improv
metabol
outcom
patient
health
follow
islet
transplant
oconnel
et
al
professor
tom
kay
head
islet
transplant
program
svh
comment
thought
pretti
seriou
sideeffect
manag
justifi
oconnel
though
islet
transplant
rapidli
develop
past
decad
temporarili
halt
period
due
concern
possibl
contamin
pancreat
islet
march
research
becam
awar
enzym
use
extract
islet
cell
produc
solut
contain
tissu
cow
brain
sinnema
enzym
manufactur
us
roch
appli
scienc
canadian
journalist
jodi
sinnema
report
roch
supplier
use
fat
tissu
cow
brain
enhanc
growth
bacteria
produc
enzym
time
bovin
spongiform
encephalopathi
bse
identifi
us
small
number
report
case
creutzfeldtjakob
diseas
cjd
commonli
known
brainwast
diseas
cjd
incur
fatal
neurodegen
disord
variant
cjd
vcjd
one
type
neurolog
condit
caus
consumpt
beef
product
infect
bse
mad
cow
diseas
materi
risk
contamin
underscor
prior
incid
patient
death
due
variou
medic
procedur
sinc
late
patient
contract
cjd
follow
corneal
graft
dura
mater
administr
humanderiv
pituitari
growth
hormon
magnusson
risk
cjd
associ
use
roch
enzym
identifi
nation
institut
health
nih
convey
news
shapiro
nih
made
discoveri
process
establish
islet
transplant
program
us
know
march
truli
answer
question
shapiro
conced
weber
note
inform
pamphlet
enzym
mention
cow
brain
howev
repres
roch
counter
catalogu
indic
product
design
use
research
mention
use
anim
product
even
though
specifi
particular
type
tissu
question
weber
given
risk
infecti
diseas
jdrf
intern
issu
global
moratorium
use
roch
enzym
experiment
islet
transplant
goodman
follow
month
shapiro
inform
local
media
notifi
patient
possibl
contamin
remot
risk
cjd
health
canada
estim
risk
one
million
million
weber
counsel
also
provid
islet
recipi
part
world
patient
receiv
islet
transplant
worldwid
includ
almost
patient
clinic
islet
transplant
program
univers
alberta
sinnema
australia
six
patient
undergon
islet
transplant
westmead
hospit
goodman
case
infect
thu
far
identifi
shapiro
announc
program
would
place
hold
could
procur
suitabl
altern
enzym
well
necessari
approv
relev
govern
author
neil
cashman
clinic
neurologist
neuroscientist
univers
british
columbia
express
strong
critic
technic
mishapproduct
made
cattl
brain
mediev
find
distress
still
product
like
dr
shapiro
would
use
protocol
without
even
know
diabet
program
u
worldrenown
find
stage
enzym
grown
bacteria
expos
cow
brain
realli
distress
sinnema
use
bovin
tissu
product
roch
digest
enzym
demonstr
way
anim
materi
deepli
embed
contemporari
system
manufactur
product
context
biomed
research
depend
anim
bodi
taken
grant
overlook
even
lead
expert
work
field
jdrf
moratorium
coincid
midpoint
australian
moratorium
animaltohuman
transplant
iron
precautionari
ban
xenotransplant
offer
protect
risk
infecti
diseas
way
avail
earli
recipi
experiment
islet
allograft
clearli
indic
need
vigil
whether
scientist
experi
biolog
materi
sourc
anim
human
donor
without
safe
digest
enzym
australian
islet
transplant
program
delay
mani
month
goodman
cours
full
complianc
jdrf
moratorium
unreason
time
australian
transplant
commun
encount
incid
zoonosi
result
death
three
transplant
recipi
illfat
transplant
took
place
toward
end
two
metropolitan
hospit
royal
melbourn
hospit
austin
hospit
heidelberg
victoria
seven
year
later
victorian
coron
issu
report
caus
patient
death
may
coron
court
victoria
transplant
donor
travel
serbia
month
visit
mother
resid
rural
properti
upon
return
australia
patient
becam
ill
experienc
consider
weight
loss
die
brain
haemorrhag
earli
decemb
expert
specul
donor
may
contract
viru
abroad
anderson
identifi
agent
novel
viru
compar
arenaviru
known
lymphocyt
choriomening
viru
lcmv
palacio
et
al
sinc
lcmv
link
sever
cluster
patient
death
follow
transplant
four
state
us
singh
et
al
viru
contract
exposur
rodent
includ
rat
mice
hamster
lcmv
infect
gener
caus
mild
flulik
symptom
immunocompet
patient
howev
case
immunosuppress
patient
may
result
seriou
symptom
enceph
acut
inflamm
brain
follow
death
donor
liver
kidney
retriev
transplant
three
femal
patient
decemb
infect
organ
result
humantohuman
transmiss
lcmvlike
viru
first
patient
death
occur
new
year
day
remain
two
death
took
place
end
week
current
univers
test
organ
donor
arenaviru
form
part
standard
practic
transplant
singh
et
al
accord
medic
epidemiologist
us
center
diseas
control
prevent
avail
diagnost
test
arenaviru
wide
avail
may
take
week
perform
smith
victorian
coron
found
lcmvlike
viru
underli
caus
death
three
organ
recipi
conclud
screen
process
adopt
organ
retriev
reason
appropri
circumst
could
ad
addit
inform
like
alter
outcom
coron
court
victoria
b
c
coron
find
base
part
submiss
made
surgeon
involv
organ
procur
transplant
professor
robert
jone
director
liver
transplant
unit
austin
hospit
submit
particular
liver
donor
dandenong
fact
good
organ
work
well
certainli
concern
would
feel
signific
risk
donor
would
turn
donor
say
everi
donor
accept
accept
risk
organ
may
work
may
transmit
diseas
may
caus
problem
weigh
recipi
may
die
otherwis
coron
court
victoria
given
comment
clear
organ
transplant
involv
apprais
cost
benefit
wherebi
access
technolog
transplant
condit
margin
though
potenti
seriou
risk
diseas
possibl
safeguard
unknown
diseas
neither
safeguard
effect
test
known
diseas
yet
design
implement
screen
procedur
addit
case
lcmv
lcmvlike
arenaviru
infect
found
organ
recipi
includ
parasit
rabi
hiv
west
nile
viru
chaga
diseas
herp
simplex
viru
hepat
b
hepat
c
virus
fishman
ast
infecti
diseas
commun
practic
thu
similarli
practic
xenotransplant
patient
seek
organ
transplant
bear
risk
contract
infecti
diseas
identifi
exist
screen
process
moreov
incid
catalys
debat
whether
australia
introduc
polici
inform
patient
variabl
organ
qualiti
sunday
age
surviv
partner
one
deceas
patient
remark
partner
would
thought
twice
transplant
oper
awar
donat
kidney
borderlin
elder
experiment
islet
transplant
long
histori
canada
australia
highli
like
transplant
partial
human
pancrea
perform
sir
john
ramsay
tasmania
first
allograft
kind
world
similarli
note
frederick
bant
attempt
canin
tissu
transplant
follow
success
research
insulin
recent
asid
continu
scientif
research
countri
canada
australia
also
subject
social
scienc
investig
nation
respons
xenotransplant
due
anticip
xenotransplant
clinic
trial
canadian
australian
research
jurisdict
respond
initi
engag
public
polici
decisionmak
countri
outcom
mix
local
global
well
fusion
technic
expertis
lay
perspect
concern
human
experiment
use
anim
bodi
biomed
experiment
toward
end
canada
began
systemat
undertak
nation
public
consult
xenotransplant
address
public
health
risk
associ
socioeth
legal
scientif
challeng
einsiedel
ross
canadian
scholar
einsiedel
ross
argu
process
public
consult
substant
contribut
canadian
debat
xenotransplant
two
way
firstli
facilit
pluralis
knowledg
allow
marginalis
voic
heard
secondli
offer
public
opportun
consid
risk
benefit
technolog
expert
einsiedel
ross
follow
nation
public
consult
canada
effect
prioritis
role
public
delay
introduct
standard
clinic
xenotransplant
anoth
defin
aspect
canadian
respons
absenc
offici
nation
polici
xenotransplant
einsiedel
et
al
suggest
lack
articul
polici
could
read
decis
einsiedel
et
al
though
nondecis
highli
ambigu
may
also
workabl
realist
posit
adopt
given
field
constrain
uncertainti
regard
risk
infecti
diseas
introduct
canadian
xenotransplant
standard
criticis
undermin
public
health
concern
inconsist
princip
recommend
nation
consult
mortensen
howev
absenc
explicit
polici
commit
moratorium
fix
durat
could
argu
canadian
approach
suffici
pliabl
accommod
compet
nation
prioriti
public
safeti
promot
biotechnolog
innov
xenotransplant
less
contest
polit
issu
canada
us
uk
oppon
contest
research
law
court
einsiedel
et
al
addit
canadian
public
engag
xenotransplant
also
facilit
institut
learn
role
public
public
particip
policymak
within
health
canada
jone
einsiedel
contrast
canadian
respons
australian
polici
xenotransplant
made
remad
feder
agenc
govern
medic
research
nhmrc
australian
scientist
among
activ
research
transplant
medicin
also
particip
develop
global
local
regulatori
standard
clinic
xenotransplant
australian
nation
inquiri
xenotransplant
took
place
compar
inquiri
complet
jurisdict
posit
draw
upon
learn
experi
countri
includ
canada
nhmrc
shift
precautionari
approach
permiss
regul
xenotransplant
consist
polici
adopt
develop
countri
includ
canada
new
zealand
unit
state
european
union
though
nhmrc
indic
issu
guidelin
anim
human
studi
document
appear
avail
websit
within
consensu
model
decisionmak
australian
effort
engag
experiment
democraci
appear
becom
undon
compet
nation
prioriti
scientif
innov
took
preced
note
conflict
view
whether
public
consult
necessari
requir
lift
nation
ban
xenotransplant
work
parti
xwp
nation
health
medic
research
council
nhmrc
subsequ
public
consult
take
place
canada
howev
unlik
canadian
social
scienc
research
compar
empir
research
conduct
assess
whether
institut
learn
regard
import
public
particip
develop
health
research
polici
nhmrc
public
controversi
islet
allograft
xenograft
render
visibl
ambigu
taken
grant
boundari
concern
speci
differ
knowledg
product
risk
manag
transplant
surgeri
experiment
note
australian
ban
clinic
xenotransplant
coincid
jdrf
moratorium
islet
allotransplant
incid
illustr
risk
infecti
diseas
problemat
xenotransplant
also
allotransplant
stringent
measur
necessari
regul
experiment
routin
transplant
iron
ban
xenotransplant
clinic
trial
provid
protect
patient
way
avail
transplant
recipi
research
particip
receiv
islet
allograft
edmonton
protocol
report
xenotransplant
nhmrc
omit
discuss
jdrf
global
moratorium
context
islet
allograft
yet
allotransplant
also
import
point
comparison
analysi
xenotransplant
note
nhmrc
paper
articul
claim
xenograft
may
safer
allograft
nation
health
medic
research
council
nhmrc
support
clinic
xenotransplant
nhmrc
advoc
practic
screen
sourc
pig
monitor
infecti
diseas
without
address
limit
procedur
due
possibl
human
error
rigor
robust
approach
regul
clinic
xenotransplant
would
also
need
take
account
potenti
accid
inadvert
british
biochemist
nobel
laureat
richard
robert
made
obviou
point
succinctli
human
human
peopl
make
mistak
sampl
expiri
xenotransplant
moratorium
canada
australia
elsewher
remain
seen
clinic
research
field
unfold
whether
develop
virolog
bear
futur
trajectori
experiment
transplant
case
past
